Endovascular aneurysm repair (EVAR) has become widely adopted as the primary treatment modality for abdominal aortic aneurysm in the elective setting. However, equipoise exists regarding the use of this technology for acute ruptured aneurysms. A best evidence topic in cardiovascular surgery was written according to a structured protocol. The question addressed, whether a policy for endovascular repair as the primary mode of treatment for ruptured abdominal aortic aneurysms (rAAAs) would improve outcomes. One thousand three hundred and twenty-eight papers were found using the reported search; of these, 24 presented represent the best evidence to answer the clinical question. The author, journal, date and country of publication, patient group studies, study type, relevant outcomes, results, and study weaknesses of these papers are tabulated. The majority of data available derives from level 2b evidence, with only a single level 1b and no level 1a studies available. Appraisal of theses studies is constrained by limited patient numbers, selection bias and heterogeneity in treatment protocols between the reported series. The sole prospective randomised controlled trial comparing open and endovascular treatments found a 53% mortality amongst patients treated by either modality. This study was, however, underpowered and contrary to numerous cohort series that show reduced mortality with EVAR. The largest body of evidence is found in a co-operative multicentre cohort study spanning 49 institutions that showed superiority of EVAR over open repair in terms of 30-day mortality. We conclude that, within the limitations of the published literature to date, endovascular repair as the primary treatment for rAAA is achievable and appears to be associated with favourable mortality over open repair with appropriate case selection.
Introduction
A best evidence topic was constructed, according to a structured protocol. This protocol has been previously described in the ICVTS w1x.
Clinical scenario
A patient presents with a known abdominal aortic aneurysm (AAA) to your hospital with symptoms indicating rupture. The patient is haemodynamically stable enough to have a CT-scan, which confirms this diagnosis. The patient is treated by traditional open surgery, though it is noted that the anatomy of the aneurysm is suitable for endovascular aneurysm repair (EVAR) using a stent graft. Subsequently, the case prompts discussion about establishing a service for the treatment of ruptured abdominal aortic aneurysms (rAAAs) preferentially by EVAR. You decide to search for the evidence for this, in order to investigate whether such a service would be beneficial to patients. *Corresponding author. Tel.: q44(0) 161 2916603; fax: q44(0) 161 2916644.
E-mail address: jonathanghosh@mac.com (J. Ghosh).
Three part question
In wpatients with ruptured abdominal aortic aneurysmx does wtreatment by an endovascular repair first strategyx improve w30-day mortality in comparison to open surgeryx?
Search strategy
Medline 2005-August 2009. Aortic rupture 'wMeshx and endovascular wAll fieldsx) OR EVAR wAll fieldsx'
Series published prior to 2005 were not used for this analysis. Reports preceding this year were felt to not be translatable to contemporary endovascular practice. Studies that included symptomatic but unruptured aneurysms were discarded.
Search outcome
One thousand three hundred and twenty-eight papers were found of which 24 were deemed to be relevant to current practice and suitable for appraisal. These papers are presented in Table 1 .
Results

Direct comparison between EVAR and open surgery for
rAAA is made challenging as not all patients are anatomi-Downloaded from https://academic.oup.com/icvts/article-abstract/10/4/611/659410 by guest on 18 January 2020 Power calculation required 100 patients to be randomised; however, this was based on published data from non-randomised trials on selected patients. A much larger number may need to be randomised to provide statistically significant data given results of this study EVAR, endovascular aneurysm repair; rAAA, ruptured abdominal aortic aneurysm; eEVAR, emergency endovascular aneurysm repair; AAA, abdominal aortic aneurysm; RCT, randomised control trial; NSQIP, National Surgical Quality Improvement Programme; ICD, International Classification of Disease; ASA, American Association of Anesthetists; HR, hazards ratio. cally suitable for the former approach. In addition, haemodynamically decompensating patients may not survive the time interval for radiological assessment prior to definitive treatment. This best evidence topic search aims to determine whether an 'EVAR-first' approach to ruptured AAA is associated with favourable mortality compared to the traditional open approach. To address this clinical question, various sources of papers are to be considered. The most prevalent studies published addressing this issue are observational studies. There are a number of singlecentre cohort studies, as well as, larger observational studies of multiple centres or national datasets. There are also papers that systematically review data from multiple non-randomised, observational studies. There is just a single paper published, which reports upon a randomised control trial (RCT), reported by Hinchliffe et al. w25x . This single-centre study showed a higher EVAR related mortality compared to observational studies and did not find any overall survival advantage in the mid-to long-term with EVAR compared to open repair. Only 53% were deemed suitable for EVAR and, interestingly, the prerequisite for CT-scanning did not delay definitive surgery. A constraint Best Evidence Topic Downloaded from https://academic.oup.com/icvts/article-abstract/10/4/611/659410 by guest on 18 January 2020 to the applicability of this paper is that it is likely to be underpowered, with the authors' power calculation based on non-randomised trials in selected populations.
Numerous observational studies have been performed, whereby the outcomes of ruptured AAA are reported following the introduction of an EVAR-first protocol for the treatment of rAAA. The specifics of the protocol varied from study-to-study, and the proportion of rAAA treated by EVAR also differs. This heterogeneity reflects the inherent selection bias present in these observational studies. Notably there is considerable variance in the definition of haemodynamic stability between series. A multi-centre prospectively recruited cohort study showed near statistical significance for a 30-day survival benefit with EVAR over open surgery, although this study was constrained by variation in treatment protocols between the participating hospitals w21x.
No observational study concluded any superiority of open surgery over EVAR with reference to mortality or morbidity, two found equivalent mortality and the remainder found improved 30-day survival with EVAR. Nevertheless, limited patient numbers, selection bias and heterogeneity in treatment protocols limit the generality of such findings. Specifically, it is difficult to assess the impact of patient stability to patient selection and thus outcome. Indeed, it is pointed out by several authors that patients stable enough for CT-scanning are already a self-selecting group compared to those that are in extremis and cannot wait for imaging.
The largest body of evidence is found in a co-operative multicentre cohort study reported by Veith et al. w3x spanning 49 institutions in 13 countries. This showed superiority of EVAR over open repair in terms of 30-day mortality (median 19.7% EVAR and 36.3% open surgery; P-0.0001). Despite the large patient numbers, this study is purely observational, with no defined standard of practice in any participating centres and the carrying the potential for reporting bias.
The most contemporary single-centre comparison of outcome prior to and following after implementation of an EVAR first protocol has been reported by Starnes et al. w2x;  all patients undergoing aneurysm repair after implementation of an EVAR-first protocol were compared to an historical comparison. After implementation of a structured EVAR protocol, overall 30-day mortality fell from 54.2% to 18.5%. Once implemented, 30-day mortality for EVAR compared extremely favourably compared to open surgery (18.5% vs. 54.2%). It is noteworthy, that EVAR related mortality reduced over time, and the proportion of rAAA that were deemed appropriate for emergency endovascular aneurysm repair (eEVAR) increased, suggesting improved outcomes associated with increased experience.
Finally, synthesis of published data has been performed in systematic reviews and meta-analyses. Karkos et al. w4x found that, in institutions performing both procedures, overall mortality following undergoing endovascular repair was lower than open (24.5% vs. 44.4%). Similarly, Rayt et al. w14x found the post-EVAR mortality and morbidity rates to be 24% and 44%, respectively, comparing favourably with published outcomes of open surgery. Funnel plots of mortality data, however, did suggest possibility of publica-tion bias in favour for EVAR and both reviews comment on the potential for bias in the source data w6, 16x. These biases will be reduced following synthesis of future level 1b evidence, such as the forthcoming IMPROVE trial (www.improvetrial.org), though it should be noted that such data is still several years away.
Clinical bottom line
Endovascular repair as the primary treatment for ruptured AAA is achievable and appears to be associated with favourable mortality over open repair with appropriate case selection. Appraisal is, however, constrained by heterogeneity between individual series, bias and dependence on predominantly level 2b data. J. Foster et al. / Interactive CardioVascular and Thoracic Surgery 10 (2010) Several earlier studies have demonstrated that EVAR is associated with reduced mortality rates for the management of ruptured AAAs compared with open AAA repair w2, 3x.
A recent meta-analysis showed that compared with open AAA repair, EVAR is associated with a significant 38% reduction in 30-day mortality wpooled odds ratio 0.624; 95% confidence interval (CI), 0.518-0.752; P-0.0001x, a shorter intensive care unit (pooled effect size estimate -0.70 days; 95% CI, -1.05 to -0.35 days; P-0.0001) and hospital stay (pooled effect size estimate -0.33 days; 95% CI, -0.50 to -0.16 days; Ps0.0001), as well as a significant reduction in blood loss (pooled effect size estimate -1.88 l; 95% CI, -2.49 to -1.27 l; P-0.0001) and procedure time (pooled effect size estimate -0.65 h; 95% CI, -0.95 to -0.36 h; Ps0.0001) for the management of acute (ruptured and symptomatic intact) AAAs w3x.
Although it is probably a fact that EVAR should be preferred over open AAA repair for the management of ruptured AAAs, there are some practical difficulties. Firstly, not all hospitals may have the appropriate personnel for the performance of EVAR on a 24-h/day basis; the associated cost implications are substantial (if not prohibitive). In addition, each hospital should maintain an appropriate stock of materials required for emergency EVAR (e.g. catheters, stent grafts). Such an action also has considerable cost implications. This could be compensated for by having dedicated regional centers although this creates other problems, such as time required to reach the center and whether a specialist team could potentially handle more than one case within a certain time interval.
On the other hand, as the authors mention w1x, not all patients presenting with ruptured AAAs will be hemodynamically stable to undergo a detailed CT-scan examination for the evaluation of the appropriateness of the AAA for EVAR. A large percentage of these patients reach the hospital in a state of hemodynamic instability w4x. For these patients, the option of EVAR is not an issue. Finally, a considerable percentage of ruptured AAAs will not be anatomically suitable for EVAR w2, 5x.
EVAR should indeed be the first option in patients with ruptured (but hemodynamically stable) AAAs. However, it may be incorrect to support that offering EVAR as the primary treatment option for ruptured AAAs is achievable. The considerable costs associated with EVAR may render such a strategy incompatible with reality.
